UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5476
Heron Therapeutics
HRTX
$55.6M
| $1.28M | ﹤0.01% |
2,997,073
+711,190
| +31% | +$570K |
2014 Q4
46 quarters
|
|
5477
Sprott Physical Copper Trust
SCOP
$187M
| $1.28M | ﹤0.01% |
+112,058
| New | +$1.34M |
2026 Q2
0 quarters
|
|
5478
Nuvectis Pharma
NVCT
$719M
| $1.27M | ﹤0.01% |
69,200
+30,637
| +79% | +$343K |
2023 Q2
12 quarters
|
|
5479
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$114M
| $1.27M | ﹤0.01% |
78,168
-212
| -0.3% | -$3.36K |
2014 Q4
46 quarters
|
|
5480
Fidelity Corporate Bond ETF
FCOR
$365M
| $1.27M | ﹤0.01% |
26,867
+1,481
| +6% | +$70K |
2016 Q1
41 quarters
|
|
5481
Spruce Biosciences
SPRB
$134M
| $1.26M | ﹤0.01% |
23,381
+19,462
| +497% | +$1.09M |
2025 Q3
3 quarters
|
|
5482
PUT
AngloGold Ashanti
AU
$47B
| $1.26M | ﹤0.01% |
15,600
+15,000
| +2,500% | +$1.42M |
2025 Q3
3 quarters
|
|
5483
GSI Technology
GSIT
$116M
| $1.26M | ﹤0.01% |
162,595
-143,154
| -47% | -$1.14M |
2022 Q4
14 quarters
|
|
5484
Fractyl Health
GUTS
$12.3M
| $1.25M | ﹤0.01% |
131,657
-3,523
| -3% | -$30.1K |
2024 Q2
8 quarters
|
|
5485
First Trust Limited Duration Investment Grade Corporate ETF
FSIG
$1.54B
| $1.25M | ﹤0.01% |
66,438
+2,026
| +3% | +$38.4K |
2026 Q1
1 quarter
|
|
5486
Sturm, Ruger & Co
RGR
$798M
| $1.25M | ﹤0.01% |
33,049
-107,688
| -77% | -$4.33M |
2014 Q4
46 quarters
|
|
5487
VanEck Low Carbon Energy ETF
SMOG
$126M
| $1.25M | ﹤0.01% |
8,555
-1,284
| -13% | -$191K |
2014 Q4
46 quarters
|
|
5488
PIMCO Income Strategy Fund II
PFN
$628M
| $1.25M | ﹤0.01% |
175,291
+92,752
| +112% | +$645K |
2014 Q4
46 quarters
|
|
|
KVUE
5489
CALL
DELISTED
Kenvue
KVUE
| $1.25M | ﹤0.01% |
65,400
-14,000
| -18% | -$247K |
2025 Q1
5 quarters
|
|
5490
Peoples Bancorp of North Carolina
PEBK
$219M
| $1.25M | ﹤0.01% |
28,953
+21,326
| +280% | +$885K |
2014 Q4
46 quarters
|
|
5491
iShares MSCI Brazil Small-Cap ETF
EWZS
$330M
| $1.24M | ﹤0.01% |
95,791
+89,771
| +1,491% | +$1.29M |
2015 Q1
45 quarters
|
|
5492
Sabine Royalty Trust
SBR
$958M
| $1.24M | ﹤0.01% |
16,980
-4,914
| -22% | -$370K |
2014 Q4
46 quarters
|
|
5493
Bombardier Recreational Products
DOO
$4.6B
| $1.24M | ﹤0.01% |
20,350
-249,519
| -92% | -$15M |
2018 Q3
31 quarters
|
|
5494
CALL
Upstart Holdings
UPST
$2.17B
| $1.24M | ﹤0.01% |
+35,000
| New | +$1.08M |
2026 Q2
0 quarters
|
|
5495
Presidio Production Co
FTW
$304M
| $1.24M | ﹤0.01% |
101,919
+42,098
| +70% | +$482K |
2025 Q1
5 quarters
|
|
5496
Sohu.com
SOHU
$361M
| $1.24M | ﹤0.01% |
102,230
+12,289
| +14% | +$176K |
2014 Q4
46 quarters
|
|
5497
PUT
Fidelity National Information Services
FIS
$14.8B
| $1.24M | ﹤0.01% |
31,800
| – | – |
2022 Q4
14 quarters
|
|
5498
AMERISAFE
AMSF
$363M
| $1.24M | ﹤0.01% |
36,518
-34,739
| -49% | -$1.1M |
2015 Q1
45 quarters
|
|
5499
Central Puerto
CEPU
$1.49B
| $1.23M | ﹤0.01% |
83,093
+27,587
| +50% | +$416K |
2023 Q4
10 quarters
|
|
5500
Ovid Therapeutics
OVID
$557M
| $1.23M | ﹤0.01% |
458,917
+181,261
| +65% | +$468K |
2019 Q4
26 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.